Aurobindo USA Can't Get Out Of Crestor MDL: Judge

Law360 (February 26, 2009, 12:00 AM EST) -- A federal judge has kept Aurobindo Pharma USA Inc. in multidistrict patent litigation over AstraZeneca Pharmaceutical LP's blockbuster drug Crestor despite objections that the court lacks subject matter jurisdiction over the U.S. subsidiary of Indian generics maker Aurobindo Pharma Ltd.

Judge Joseph J. Farnan Jr. of the U.S. District Court for the District of Delaware opted Wednesday to adopt in full the report and recommendations of Magistrate Judge Leonard P. Stark.

The report — issued in late November in response to a slew of pretrial motions...
To view the full article, register now.